Skip to main content

Table 1 Demographic, clinical, functional, and pharmacological variables

From: Executive functioning but not IQ or illness severity predicts occupational status in bipolar disorder

 

Active

(n = 86)

Inactive

(n = 34)

Statistics F

p-value

Demographics, mean (SD)

 Age, years

35.3 (10.8)

40.0 (13.5)

4.01

0.048

Clinical features, mean (SD)

 Age at onset, years

16.2 (3.8)

16.4 (4.6)

0.07

0.793

 Age at first therapy, years

26.7 (8.0)

24.6 (10.7)

1.14

0.288

 Total number of manic episodes

2.0 (3.6)

2.4 (3.1)

0.35

0.556

 Total number of depressive episodes

9.2 (14.0)

13.3 (15.1)

2.03

0.157

 MADRS score

3.4 (3.2)

4.0 (3.8)

0.54

0.463

 YMRS score

1.7 (2.4)

2.1 (3.0)

0.50

0.483

 GAF symptom score

69.7 (9.7)

63.1 (9.0)

11.54

0.001

 GAF function score

69.7 (9.7)

63.9 (9.5)

8.63

0.004

 CGI (total)

4.5 (0.9)

4.6 (1.2)

0.41

0.524

Sheehan disability scalea, mean (SD)

 Work/school

4.2 (3.4)

7.1 (3.4)

14.41

< 0.001

 Social life

3.6 (3.2)

5.6 (2.7)

7.71

0.007

 Family life/home responsibilities

2.6 (2.9)

5.2 (2.3)

17.80

< 0.001

 

Active

(n = 86)

Inactive

(n = 34)

χ2

p-value

Sex, no. (%)

  

0.57

0.451

 Female

52 (60.5)

18 (52.9)

  

 Male

34 (39.5)

16 (47.1)

  

Diagnosis, no. (%)

  

1.09

0.297

 Bipolar I disorder

54 (63.5)

25 (73.5)

  

 Bipolar II disorder

31 (36.5)

9 (26.5)

  

University studies

52 (61.2)

15 (44.1)

2.87

0.090

Comorbidity, no. (%)

 ADHD

11 (15.7)

6 (22.2)

0.57

0.450

 Anxiety disorderb

15 (17.4)

10 (29.4)

2.12

0.146

Clinical features, no. (%)

 Lifetime history of psychotic symptoms

43 (50.6)

24 (70.6)

3.95

0.047

 History of involuntary psychiatric care

38 (44.7)

22 (64.7)

3.87

0.049

 History of alcohol abuse

16 (19.5)

9 (26.5)

0.69

0.407

 History of substance abuse

9 (10.8)

6 (18.2)

1.13

1.129

Type of current medication, no. (%)

 Lithium

53 (61.6)

20 (58.8)

0.08

0.777

 Antidepressants

32 (37.2)

15 (44.1)

0.49

0.485

 Anticonvulsants

24 (27.9)

15 (44.1)

2.92

0.088

 Antipsychotics

23 (26.7)

9 (26.5)

0.00

0.976

 Central stimulants

2 (2.3)

3 (8.8)

2.58

0.108

 Benzodiazepines

17 (19.8)

15 (44.1)

7.39

0.007

  1. MADRS Montgomery-Åsberg Depression Rating Scale, YMRS Young Ziegler Mania Rating Scale, GAF Global Assessment of Functioning Scale, CGI Clinical Global Impression Rating Scale
  2. aSheehan Disability Scale is a self-report scale in which patients rate to what extent their functioning in three different life areas is impaired by psychiatric symptomatology (0 = not at all, 1–3 = mildly, 4–6 = moderately, 7–9 = markedly, 10 = extremely)
  3. bAnxiety disorders include the following DSM-IV diagnoses: generalized anxiety disorder, panic disorder, agoraphobia, social anxiety disorder, obsessive–compulsive disorder, and post-traumatic stress disorder